SmokeHaz: systematic reviews and meta-analyses of the effects of smoking on respiratory health

Article English OPEN
Jayes, Leah ; Haslam, Patricia L. ; Gratziou, Christina G. ; Powell, Pippa ; Britton, John ; Vardavas, Constantine ; Jimenez-Ruiz, Carlos ; Leonardi-Bee, Jo (2016)
  • Publisher: Elsevier
  • Journal: Chest, volume 150, issue 1, pages 164-179 (issn: 0012-3692)
  • Related identifiers: doi: 10.1016/j.chest.2016.03.060
  • Subject: Pulmonary and Respiratory Medicine | Cardiology and Cardiovascular Medicine | Critical Care and Intensive Care Medicine

Background: Smoking tobacco increases the risk of respiratory disease in adults and children, but communicating the magnitude of these effects in a scientific manner that is accessible and usable by public and policymakers presents a challenge. We have therefore summarised scientific data on the impact of smoking on respiratory diseases to provide the content for a unique resource, SmokeHaz. \ud \ud Methods: We conducted systematic reviews and meta-analyses of longitudinal studies (published to 2013) identified from electronic databases, grey literature, and experts. Random effect meta-analyses were used to pool the findings.\ud \ud Results: We included 216 papers. Among adult smokers, we confirmed substantially increased risks of lung cancer (Risk Ratio (RR) 10.92, 95% CI 8.28-14.40; 34 studies), COPD (RR 4.01, 95% CI 3.18-5.05; 22 studies) and asthma (RR 1.61, 95% CI 1.07-2.42; 8 studies). Exposure to passive smoke significantly increased the risk of lung cancer in adult non-smokers; and increased the risks of asthma, wheeze, lower respiratory infections, and reduced lung function in children. Smoking significantly increased the risk of sleep apnoea, and asthma exacerbations in adult and pregnant populations; and active and passive smoking increased the risk of tuberculosis. \ud \ud Conclusions: These findings have been translated into easily digestible content and published on the SmokeHaz website (www.smokehaz.eu).
  • References (185)
    185 references, page 1 of 19

    1. European Commission. Attitudes of Europeans Towards Tobacco and Electronic Cigarettes. 2015. http://ec. europa.eu/public_opinion/archives/ebs/ ebs_429_en.pdf. Accessed June 13, 2016.

    2. Royal College of Physicians. Passive Smoking and Children. A Report by the Tobacco Advisory Group. London, UK: Royal College of Physicians; 2010.

    3. World Health Organization. Framework Convention on Tobacco Control (FCTC). 2014.

    4. European Respiratory Society. SmokeHaz: a scientific review of the health hazards of smoking. http://www.europeanlung.org/ en/projects-and-research/projects/ smokehaz/home. Accessed April 1, 2013.

    5. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www. ohri.ca/programs/clinical_epidemiology/ oxford.asp. Accessed February 27, 2013.

    6. Shea B, Grimshaw J, Wells G, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.

    7. Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.

    8. Stroup D, Berlin J, Morton S, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.

    9. Moher D, Liberati A, Telzlaff J, Altman D, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. PLoS Med. 2009;6(6):e1000097.

    10. Al-Delaimy WK, Willett WC. Toenail nicotine level as a novel biomarker for lung cancer risk. Am J Epidemiol. 2011;173(7):822-828.

  • Related Research Results (2)
  • Metrics
    No metrics available
Share - Bookmark